Buscar
-
Neuromodulation Treatments of Pathological Anxiety in Anxiety Disorders, Stressor-Related Disorders, and Major Depressive Disorder: A Dimensional Systematic Review and Meta-Analysis
(Frontiers in Psychiatry. vol. 13, 2022-07-01)Article de revueLibre acceso -
Impact of Covid-19 Vaccination on Spontaneous Pharmacovigilance Reporting in France
(Drug Safety. vol. 46, n° 12, pp. 1381-1389, 2023-12-01)Article de revue -
Safety of Dual Orexin Receptor Antagonist Daridorexant: A Disproportionality Analysis of Publicly Available FAERS Data
(Pharmaceuticals (Basel). vol. 17, n° 3, 2024-03-06)Article de revueLibre acceso -
Resective epilepsy surgery and its impact on depression in adults: a systematic review, meta-analysis, and implications for future research
(Journal of Neurology, Neurosurgery and Psychiatry, 2024-03-05)Article de revue -
Peer Review in Pharmacovigilance: Lens on Disproportionality Analysis
(Drug Safety, 2024-03-18)Article de revue -
Safety Profile of Ibrutinib: An Analysis of the WHO Pharmacovigilance Database
(Frontiers in Pharmacology. vol. 12, pp. 769315, 2021-10-28)Article de revueLibre acceso -
Hyper inflammatory syndrome following COVID-19 mRNA vaccine in children: A national post-authorization pharmacovigilance study
(The Lancet Regional Health - Europe. vol. 17, 2022-06)Article de revueLibre acceso -
Quelle place pour l’automatisation intelligente et l’intelligence artificielle pour préserver et renforcer l’expertise en vigilance devant l’augmentation des déclarations ?
(Therapies. vol. 78, n° 1, pp. 115-129, 2022-11-25)Article de revue